MFSD2A (NLS1) (C-Terminus) (Cytoplasmic) Antibody - Western Blot Validated

Biological Background

When control selection matters, this antibody helps you characterize MFSD2A C-Terminus (NLS1) in a structured study. MFSD2A C-Terminus is a contact-site protein that shapes barrier properties and signaling at the cell surface. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

In some datasets and protocols, it is referenced by the gene symbol NLS1.

Use in the Laboratory

Junction proteins are frequently analyzed during differentiation, stress responses, and changes in cell polarity. Time course design can be decisive when regulation is transient or compartment dependent. Blood-brain barrier models often monitor junction regulation alongside permeability-focused measurements.

Depending on the model, researchers may ask whether signal shifts reflect altered abundance, compartment changes, or remodeling of associated complexes.

To keep datasets interpretable, labs often document:

• changes in complex assembly with scaffold or adaptor proteins
• comparative profiling across cell states or perturbations
• co-localization patterns with cytoskeletal elements

Version Notes

If your primary readout depends on denatured protein presentation, this option can streamline comparison across lanes and conditions. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding. Predefine decision rules for excluding outliers so analysis remains transparent.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so MFSD2A C-Terminus patterns can be compared across experiments without guesswork.

Use the denaturing-format option to keep MFSD2A C-Terminus (NLS1) analysis aligned with planned contrasts and endpoints.